Predictions
Avadel Pharmaceuticals plc ADR
Start price
Target price
Perf. (%)
€6.10
08.10.22
08.10.22
-
08.10.23
08.10.23
-0.82%
15.10.22
15.10.22
Clinuvel Pharmaceuticals
Start price
Target price
Perf. (%)
€12.30
07.10.22
07.10.22
-
07.11.22
07.11.22
2.16%
08.11.22
08.11.22
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.88
07.10.22
07.10.22
-
07.10.23
07.10.23
-41.15%
08.11.22
08.11.22
Cellectis SA ADR
Start price
Target price
Perf. (%)
€2.32
07.10.22
07.10.22
€5.00
07.10.23
07.10.23
-43.97%
08.10.23
08.10.23
Could be worthwhile Investment >10% per year
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€338.70
07.10.22
07.10.22
€350.00
07.10.23
07.10.23
7.12%
29.10.22
29.10.22
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€6.75
06.10.22
06.10.22
€0.000
06.10.23
06.10.23
-61.11%
24.10.22
24.10.22
Probably not worthwhile Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Carbylan Therapeutics Inc
Start price
Target price
Perf. (%)
€5.20
06.10.22
06.10.22
-
06.10.23
06.10.23
-7.54%
15.10.22
15.10.22
Ampio Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€0.060
06.10.22
06.10.22
€0.10
06.10.23
06.10.23
0.00%
06.10.23
06.10.23
Eurobio scientific
Start price
Target price
Perf. (%)
€17.24
05.10.22
05.10.22
€18.00
05.10.23
05.10.23
-24.25%
06.10.23
06.10.23
Could be worthwhile Investment >10% per year
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€14.42
03.10.22
03.10.22
-
03.10.23
03.10.23
-81.66%
07.10.22
07.10.22
Risky Investment
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€14.38
03.10.22
03.10.22
€7.00
03.10.23
03.10.23
-44.51%
06.10.22
06.10.22
Good culture
Probably not worthwhile Investment
Below average Management
No Innovation
Inovio Pharma
Start price
Target price
Perf. (%)
€1.74
03.10.22
03.10.22
€2.35
03.10.23
03.10.23
-15.49%
13.02.23
13.02.23
Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Neurosearch As Nam.
Start price
Target price
Perf. (%)
€27.00
03.10.22
03.10.22
-
03.10.23
03.10.23
87.41%
24.04.23
24.04.23
Probably not worthwhile Investment
Pieris Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€1.15
03.10.22
03.10.22
-
03.10.23
03.10.23
-7.38%
15.10.22
15.10.22
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€1.97
02.10.22
02.10.22
-
02.10.23
02.10.23
21.96%
18.05.23
18.05.23
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€1.11
02.10.22
02.10.22
-
02.10.23
02.10.23
-8.11%
02.04.23
02.04.23
Zealand Pharma A/s
Start price
Target price
Perf. (%)
€22.80
01.10.22
01.10.22
€11.00
01.10.23
01.10.23
8.33%
15.10.22
15.10.22
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.50
01.10.22
01.10.22
€5.00
01.10.23
01.10.23
-70.29%
15.10.22
15.10.22
Biogen Inc.
Start price
Target price
Perf. (%)
€272.50
30.09.22
30.09.22
€400.00
31.12.24
31.12.24
4.59%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year